The Research and Development team at Rigel Pharmaceuticals is dedicated to the discovery and advancement of innovative small-molecule therapies targeting immune diseases and cancers. This multidisciplinary group collaborates on drug design, preclinical and clinical research, regulatory affairs, and medical communications, working to translate scientific discoveries into impactful treatments that improve patient outcomes.
Aaron Sheppard
Senior Medical Director, Medic...
Asif M.
Vice President, Global Regulat...
Bhushan Samant
DMPK Associate Scientist
Dan Magilavy
Vice President Clinical Resear...
Elizabeth Franklin
Clinical Research Associate
Esteban Masuda
SVP, Research
Jiaxin Yu
Senior Staff Scientist
Yuliya Kreychman Pha...
Senior Director, Medical Scien...
View all